Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 957913, 7 pages
http://dx.doi.org/10.1155/2013/957913
Research Article

Killing Effect of Ad5/F35-APE1 siRNA Recombinant Adenovirus in Combination with Hematoporphrphyrin Derivative-Mediated Photodynamic Therapy on Human Nonsmall Cell Lung Cancer

1Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China
2Department of Thoracic Surgery, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China
3Department of Pathology, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China

Received 26 July 2012; Accepted 4 October 2012

Academic Editor: Tobias Kiesslich

Copyright © 2013 Lei Xia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, L. X. Clegg, E. Ward et al., “Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival,” Cancer, vol. 101, no. 1, pp. 3–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Kamangar, G. M. Dores, and W. F. Anderson, “Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world,” Journal of Clinical Oncology, vol. 24, no. 14, pp. 2137–2150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Ding, Q. Xu, F. Liu et al., “Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation,” Cancer Letters, vol. 216, no. 1, pp. 43–54, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Kato, J. Usuda, T. Okunaka et al., “Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital,” Lasers in Surgery and Medicine, vol. 38, no. 5, pp. 371–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Agostinis, K. Berg, and K. A. Cengel, “Photodynamic therapy of cancer: an update,” CA: A Cancer Journal for Clinicians, vol. 61, no. 4, pp. 250–281, 2011. View at Google Scholar
  6. J. M. Dabrowski, L. G. Arnaut, and M. M. Pereira, “Combined effects between singlet oxygen and hydroxyl radical in photodynamic therapy with photostable bacteriochlorins:evidence from intracellular fluorescence and increased photodynamic efficacy in vitro,” Free Radical Biology & Medicine, vol. 52, no. 7, pp. 1188–1200, 2012. View at Google Scholar
  7. F. Puglisi, G. Aprile, A. M. Minisini et al., “Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas,” Anticancer Research, vol. 21, no. 6, pp. 4041–4049, 2001. View at Google Scholar · View at Scopus
  8. A. R. Evans, M. Limp-Foster, and M. R. Kelley, “Going APE over ref-1,” Mutation Research, vol. 461, no. 2, pp. 83–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. W. Kim, S. M. Bae, and G. Battogtokh, “Synergistic anti-tumor effects of combination of photodynamic therapy and arsenic compound in cervical cancer cells: in vivo and in vitro studies,” PLoS One, vol. 7, no. 6, article e38583, 2012. View at Google Scholar
  10. S. L. Manoto, P. R. Sekhejane, and N. N. Houreld, “Localization and phototoxic effect of zinc sulfophthalocyanine photosensitizer in human colon (DLD-1) and lung (A549) carcinoma cells (in vitro),” Photodiagnosis and Photodynamic Therapy, vol. 9, no. 1, pp. 52–59, 2011. View at Google Scholar
  11. E. Jedrych, M. Chudy, and A. Dybko, “The microfluidic system for studies of carcinoma and normal cells interactions after photodynamic therapy (PDT) procedures,” Biomicrofluidics, vol. 5, no. 4, pp. 41101–411016, 2011. View at Google Scholar
  12. K. A. Ziel, C. C. Campbell, G. L. Wilson, and M. N. Gillespie, “Ref-1/Ape is critical for formation of the hypoxia-inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene,” FASEB Journal, vol. 18, no. 9, pp. 986–988, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Nguyen, E. M. Menocal, J. Harborth, and J. H. Fruehauf, “RNAi therapeutics: an update on delivery,” Current Opinion in Molecular Therapeutics, vol. 10, no. 2, pp. 158–167, 2008. View at Google Scholar · View at Scopus
  14. P. J. Paddison, A. A. Caudy, and G. J. Hannon, “Stable suppression of gene expression by RNAi in mammalian cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 3, pp. 1443–1448, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. T. R. Brummelkamp, R. Bernards, and R. Agami, “A system for stable expression of short interfering RNAs in mammalian cells,” Science, vol. 296, no. 5567, pp. 550–553, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. C. P. Paul, P. D. Good, I. Winer, and D. R. Engelke, “Effective expression of small interfering RNA in human cells,” Nature Biotechnology, vol. 20, no. 5, pp. 505–508, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. D. J. Shuey, D. E. McCallus, and T. Giordano, “RNAi: gene-silencing in therapeutic intervention,” Drug Discovery Today, vol. 7, no. 20, pp. 1040–1046, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Wang, M. Luo, and M. R. Kelley, “Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition,” Molecular Cancer Therapeutics, vol. 3, no. 6, pp. 679–686, 2004. View at Google Scholar · View at Scopus
  19. L. J. Walker, R. B. Craig, A. L. Harris, and I. D. Hickson, “A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress,” Nucleic Acids Research, vol. 22, no. 23, pp. 4884–4889, 1994. View at Google Scholar · View at Scopus
  20. Y. Ono, T. Furuta, T. Ohmoto, K. Akiyama, and S. Seki, “Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease,” Mutation Research, vol. 315, no. 1, pp. 55–63, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. McNeill and D. M. Wilson III, “A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents,” Molecular Cancer Research, vol. 5, no. 1, pp. 61–70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Z. Yang, X. H. Chen, and D. Wang, “Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector,” Clinical Lymphoma and Myeloma, vol. 7, no. 4, pp. 296–304, 2007. View at Publisher · View at Google Scholar · View at Scopus